誉衡药业：2025年度业绩预增公告

Core Viewpoint - Yuheng Pharmaceutical announced an expected increase in net profit for the fiscal year 2025, projecting a range of CNY 350 million to CNY 420 million, representing a growth of 50.37% to 80.44% compared to the previous year [2] Financial Performance - The company anticipates net profit attributable to shareholders to be between CNY 350 million and CNY 420 million for 2025 [2] - This projection indicates a significant year-on-year growth rate of 50.37% to 80.44% [2]